BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18629572)

  • 1. Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study.
    Cauley JA; Wampler NS; Barnhart JM; Wu L; Allison M; Chen Z; Hendrix S; Robbins J; Jackson RD;
    Osteoporos Int; 2008 Dec; 19(12):1717-23. PubMed ID: 18629572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
    Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
    Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
    Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
    J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
    Cauley JA; Chlebowski RT; Wactawski-Wende J; Robbins JA; Rodabough RJ; Chen Z; Johnson KC; O'Sullivan MJ; Jackson RD; Manson JE
    J Womens Health (Larchmt); 2013 Nov; 22(11):915-29. PubMed ID: 24131320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.
    Crandall CJ; Liu J; Cauley J; Newcomb PA; Manson JE; Vitolins MZ; Jacobson LT; Rykman KK; Stefanick ML
    Obstet Gynecol; 2017 Jul; 130(1):171-180. PubMed ID: 28594759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk factors for fractures in multi-ethnic women: the Women's Health Initiative.
    Cauley JA; Wu L; Wampler NS; Barnhart JM; Allison M; Chen Z; Jackson R; Robbins J
    J Bone Miner Res; 2007 Nov; 22(11):1816-26. PubMed ID: 17638574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.
    Chang KP; Center JR; Nguyen TV; Eisman JA
    J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between incidence of fractures and anemia in older multiethnic women.
    Chen Z; Thomson CA; Aickin M; Nicholas JS; Van Wyck D; Lewis CE; Cauley JA; Bassford T;
    J Am Geriatr Soc; 2010 Dec; 58(12):2337-44. PubMed ID: 21143442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy aging. A women's issue.
    La Croix AZ; Newton KM; Leveille SG; Wallace J
    West J Med; 1997 Oct; 167(4):220-32. PubMed ID: 9348751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
    Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    Park NJ; Chang Y; Bender C; Conley Y; Chlebowski RT; van Londen GJ; Foraker R; Wassertheil-Smoller S; Stefanick ML; Kuller LH
    PLoS One; 2017; 12(9):e0184174. PubMed ID: 28934233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
    Jackson RD; Mysiw WJ
    Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.